UNLEASH IMMUNO ONCOLYTICS
Unleash IO develops oncolytic immunotherapy products shown to be highly specific and efficacious in animal models and human tissue samples. Unleash IO’s leading product, UIO-512, is an oncolytic adenovirus that targets both malignant cells and tumor-associated stroma cells. UIO-512 is armed with GM-CSF, a potent immune-modulatory cytokine, triggering an immune response towards the tumor. UIO-512 lead indication is in ovarian cancer, follow on indications include other solid tumors such as glio... blastoma, melanoma and pancreatic cancer. Promising pre-clinical results in animal models and fresh human samples of ovarian cancers as well as in melanoma were published in top ranked peer-reviewed publications. Unleash IO is raising $3.5 M to conduct a phase I/II clinical trial in ovarian cancer with oncolytic immunotherapy UIO-512.
UNLEASH IMMUNO ONCOLYTICS
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2015-01-01
Address:
Saint Louis, Missouri, United States
Country:
United States
Website Url:
http://www.unleash.bio
Total Employee:
1+
Status:
Active
Contact:
314-730-0050
Email Addresses:
[email protected]
Total Funding:
3 M USD
Technology used in webpage:
SPF Google Apps For Business Hostgator Mail A2 Hosting
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
Nano Precision Medical
Nano Precision Medical develops novel miniaturized subdermal implants
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Symphony Biosciences
Symphony Biosciences empowers the immune system to fight cancer.
Current Employees Featured
Founder
Investors List
Oncolys BioPharma
Oncolys BioPharma investment in Venture Round - Unleash Immuno Oncolytics
Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship
Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship investment in Grant - Unleash Immuno Oncolytics
Official Site Inspections
http://www.unleash.bio
- Host name: 69.48.181.160.static.a2webhosting.com
- IP address: 69.48.181.160
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Unleash Immuno Oncolytics"
HOME - UNLEASH
We mobilize youth around the world to co-create a sustainable future UNLEASH enables young people to create solutions, become leaders, and drive networks to help reach the Sustainable …See details»
UNLEASH - LinkedIn
UNLEASH | 44,382 followers on LinkedIn. A global innovation program for the United Nations Sustainable Development Goals! | UNLEASH enables young people to create solutions, …See details»
UNLEASH - Dalberg
UNLEASH - Nonprofit Organization Management - Apollo.io
View UNLEASH location in Capital Region of Denmark, Denmark, revenue, competitors and contact information. Find and reach UNLEASH's employees by department, seniority, title, and …See details»
Home | Unleash
UNLEASH. learn more. Sherpa Organizational Change - The road to 2020. Unleash works since 2015 with Sherpa - a big healthcare institute - to co-create a new path towards 2020. A core group of 35 carefully selected employees …See details»
WHAT WE DO - UNLEASH
What we do UNLEASH offers different programs for youth to co-create a sustainable future by addressing the Sustainable Development Goals (SDGs) in their community, region, or worldwide: UNLEASH Innovation Lab, global and …See details»
Unleash Immuno Oncolytics - Overview, News & Similar
Unleash Immuno Oncolytics contact info: Phone number: (314) 201-4426 Website: unleash.bio What does Unleash Immuno Oncolytics do? Unleash Immuno Oncolytics is an immuno …See details»
Hosting an UNLEASH Innovation Lab FAQ
During the application period, UNLEASH can help your organization estimate the cost of the Innovation Lab you envision, and create different scenarios that can be adapted to a realistic …See details»
UNLEASH World 2024: The CEO’s insider guide to what’s hot
Oct 8, 2024 UNLEASH gives you the tools, techniques and trends to lead your organization through exponential change that AI brings to work and life. Reward your HR leadership team …See details»
From the bottom up: Transforming Medidata with …
Unleash reduces the risk of releasing new features, drives innovation by streamlining the software release process, and increases revenue by optimizing end-user experience. While we serve the needs of the world's largest, most …See details»
Unleash Immuno Oncolytics Overview - SignalHire
The company currently specializes in the Biotechnology area. Its headquarters is located at Louis, Missouri, USA. The Unleash Immuno Oncolytics annual revenue is estimated at < 1M. Total …See details»
Unleash Immuno Oncolytics - Company Profile & Staff Directory
Unleash IO develops oncolytic immunotherapy products shown to be highly specific and efficacious in animal models and human tissue samples. Unleash IO’s leading product, UIO …See details»
Unleash Immuno Oncolytics - Crunchbase Company Profile
Unleash IO develops oncolytic immunotherapy products shown to be highly specific and efficacious in animal models and human tissue samples. Unleash IO’s leading product, UIO …See details»
PLUS - UNLEASH
UNLEASH Plus, co-designed and co-led with Chemonics International, is a 6-month incubation program for early-stage social entrepreneurs who have a great idea and a phenomenal team. …See details»
Upcoming Events Calendar - UNLEASH
At this year’s UNLEASH America, discover cutting-edge strategies and breakthrough innovations defining tomorrow’s workplace today. Mingle with HR visionaries from over 111 countries and …See details»
DEVELOPING! GITMO Soldiers Unleash Second Spotlight—Rituals ...
Today, December 15, 2024, new revelations from Guantanamo Bay (GITMO) confirm that the second spotlight phase of operations has reached a critical juncture. Over the past 48 hours, a …See details»
Unleash Immuno Oncolytics Company Profile - Craft
Unleash Immuno Oncolytics is an immune-oncology company developing oncolytic viruses that target the stromal layer of metastatic cancers. Its lead product, UIO-623, is an oncolytic virus …See details»
INDIA LAB - UNLEASH
UNLEASH GlobalInnovation Lab India 2022 The last UNLEASH Innovation Lab took place in the state of Karnataka in India, from the December 3 – 10. The Lab gathered 1,000 young people …See details»
UNLEASH Plus 2021
The program is co-hosted by UNLEASH and Chemonics International, UNLEASH’s Lead Scale Partner for the 3 rd year in a row. The program culminated in a final competitive event, the …See details»